Utomilumab
Utomilumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Utomilumab is under investigation in clinical trial NCT03318900 (T Cell Immunotherapy for Advanced Ovarian Cancer).
| Trade Name | Utomilumab |
| Generic | Utomilumab |
| Utomilumab Other Names | PF-05082566, Utomilumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Utomilumab
